Flaherty & Crumrine Incorporated, a renowned investment management firm, has launched and is currently managing a closed-ended balanced mutual fund named Flaherty & Crumrine Preferred Securities Income Fund Inc. Investing in both public equity and fixed income markets of the United States, the fund aims to invest in preferred securities of companies operating across various sectors. The majority of the fund's investments are comprised of investment grade preferred securities in the form of hybrid or taxable preferreds, with its portfolio being created employing a quantitative analysis technique. The fund has been benchmarked against multiple indices for performance evaluation, including the Merrill Lynch 8% Capped DRD Preferred Stock Index, Merrill Lynch Hybrid Preferred Securities Index, and Merrill Lynch Adjustable Preferred Stock 7% Constrained Index. It was formerly known as Flaherty & Crumrine/Claymore Preferred Securities Income Fund Incorporated before it was rebranded as Flaherty & Crumrine Preferred Securities Income Fund Inc. in line with the company's objectives. The fund was formed on May 23, 2002, and based in the United States.
Farmaforce's ticker is FFC
The company's shares trade on the ASX stock exchange
They are based in Sydney, Australia
There are 51-200 employees working at Farmaforce
It is https://farmaforce.com.au
Farmaforce is in the Healthcare sector